We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

41 hedge funds and large institutions have $1.3M invested in Oncolytics Biotech in 2024 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

14% more funds holding

Funds holding: 36 → 41 (+5)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.15% less ownership

Funds ownership: 1.87% → 1.73% (-0.15%)

14% less capital invested

Capital invested by funds: $1.5M → $1.3M (-$203K)

Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SI
Seeds Investor
New York
+$207K
2
Jane Street
Jane Street
New York
+$13.9K
3
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$10.9K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$10.9K
5
AWM
Activest Wealth Management
Florida
+$5.45K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$228K
2
Millennium Management
Millennium Management
New York
-$43.3K
3
Citadel Advisors
Citadel Advisors
Florida
-$28K
4
VF
Virtu Financial
New York
-$26.6K
5
TSS
Two Sigma Securities
New York
-$12.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
CMA
26
Cedar Mountain Advisors
Oregon
$5.59K – – –
UBS Group
27
UBS Group
Switzerland
$5.55K +$4.83K +4,439 +381%
AWM
28
Activest Wealth Management
Florida
$4.95K +$5.45K +5,000 New
Wells Fargo
29
Wells Fargo
California
$4.36K – – –
TRCT
30
Tower Research Capital (TRC)
New York
$3.19K +$3.53K +3,239 New
IA
31
IFP Advisors
Florida
$2.48K – – –
AF
32
Allworth Financial
California
$2.06K +$2.18K +2,000 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$1.88K +$2.07K +1,900 New
Carson Wealth (CWM LLC)
34
Carson Wealth (CWM LLC)
Nebraska
$1K -$1.09K -1,000 -43%
TWC
35
TD Waterhouse Canada
Ontario, Canada
$660 +$721 +662 New
Toronto Dominion Bank
36
Toronto Dominion Bank
Ontario, Canada
$469 +$516 +474 New
JFA
37
JNBA Financial Advisors
Minnesota
$208 – – –
PP
38
Pacifica Partners
Canada
$101 +$109 +100 New
AF
39
Aviso Financial
Ontario, Canada
$55 +$61 +56 New
WWM
40
Wolff Wiese Magana
California
$31 – – –
1832 Asset Management
41
1832 Asset Management
Ontario, Canada
$5 – – –
Millennium Management
42
Millennium Management
New York
– -$43.3K -40,887 Closed
TSS
43
Two Sigma Securities
New York
– -$12.5K -11,816 Closed
JP Morgan Chase
44
JP Morgan Chase
New York
– -$12.2K -11,500 Closed
AI
45
Atom Investors
Texas
– -$10.9K -10,257 Closed
1
2

ONCY Hedge Fund Activity: Q2 2024 in Review

41 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q2 2024, worth a combined $1.3M — down 14% from $1.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ONCY positions and 4 closed out — a net gain of 6 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Seeds Investor, opening a new position worth an estimated $207K. The largest seller was Morgan Stanley, cutting an estimated $228K.

  • 41 institutional investors held Oncolytics Biotech (ONCY) as of Q2 2024, up from 36 in Q1 2024.
  • Funds reported $1.3M of Oncolytics Biotech stock for Q2 2024, down 14% quarter-over-quarter.
  • 10 funds opened new Oncolytics Biotech positions in Q2 2024 and 4 closed out, a net change of +6 holders.
  • The largest Oncolytics Biotech buyer in Q2 2024 was Seeds Investor, an estimated $207K added.
  • The largest Oncolytics Biotech seller in Q2 2024 was Morgan Stanley, an estimated $228K sold.

Based on aggregated 13F filings for Q2 2024.